María Paz Ocaranza Jeraldino,Sergio Lavandero González,Jorge Jalil Milad,Mario Chiong Lay
申请号:
US12998910
公开号:
US09132164B2
申请日:
2009.12.15
申请国别(地区):
US
年份:
2015
代理人:
摘要:
A pharmaceutical composition is provided having an effective amount of angiotensin-(1-9) and at least one pharmaceutical acceptable carrier, excipient, stabilizer, diluent, and/or adjuvant. Also provided is a method of using the pharmaceutical composition for inhibiting and/or reducing cardiovascular remodeling.